View Larger Image

FAPI-PET imaging & theranostics: A new era in targeting cancer and fibrotic diseases

Presented by: John Babish – Ratio Therapeutics, Sherly Mosessian, PhD – SOFIE Chief Scientific Officer, Jeremie Calais – Dept of Molecular and Medical Pharmacology, Ken Hermann – Nuclear Medicine Physician
Endpoints Webinars – November 7, 2024

Watch Webinar

sofie_c557hm2025-10-15T16:42:10+00:00November 7th, 2024|Webinars|

Current State of FAP Targeting Radioligands in Oncology

Gallery

Current State of FAP Targeting Radioligands in Oncology

June 18th, 2025

Amyloid Biomarker Imaging and FDG in the Era of an Approved Anti Amyloid Therapy

Gallery

Amyloid Biomarker Imaging and FDG in the Era of an Approved Anti Amyloid Therapy

March 28th, 2025

Imaging Cancer through the Stroma – FAPI PET/CT, a Novel Tracer in Oncology

Gallery

Imaging Cancer through the Stroma – FAPI PET/CT, a Novel Tracer in Oncology

November 9th, 2024

FAP Ligands for Imaging and Therapy

Gallery

FAP Ligands for Imaging and Therapy

June 12th, 2022

Fibroblast Activation Protein (FAP) – A promising target for radiopharmaceuticals

June 8th, 2022

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

FAPI-PET imaging & theranostics: A new era in targeting cancer and fibrotic diseases

Share This Story, Choose Your Platform!

Related Posts

Current State of FAP Targeting Radioligands in Oncology

Amyloid Biomarker Imaging and FDG in the Era of an Approved Anti Amyloid Therapy

Imaging Cancer through the Stroma – FAPI PET/CT, a Novel Tracer in Oncology

FAP Ligands for Imaging and Therapy

Fibroblast Activation Protein (FAP) – A promising target for radiopharmaceuticals